Ben Lamm on Innovation, Risk, and Building the Future of Biotech

In this Forbes op-ed, Colossal Biosciences CEO Ben Lamm argues that moonshot innovation — the kind that dares to bring back extinct species — is essential to solving our planet’s biggest challenges. Reflecting on his career as a serial entrepreneur, Lamm explains why high-risk, high-reward biotech projects need both public support and private investment. He positions Colossal’s de-extinction work as more than scientific spectacle; it’s a way to restore ecosystems, drive genomic innovation, and prepare for a more sustainable future. Lamm emphasizes the importance of interdisciplinary collaboration, transparency, and ethical grounding in biotech leadership. The piece ultimately challenges readers to embrace science not just for what it can do now — but for what it might unlock next.

To Learn More Click Here